R. Ikeda

Phase II study of NK105, a paclitaxel-incorporating micellar nanoparticle, for previously treated advanced or recurrent gastric cancer

T. Yoshikawa, Ken Kato, Y. Matsumura, 2012, Investigational New Drugs.

A prognostic index for the clinical management of patients with advanced prostatic cancer: A british prostate study group investigation

K. Griffiths, M. Harper, D. Wilson, 1986, The Prostate.

Phase II study of NK105, a paclitaxel-incorporating micellar nanoparticle as second-line treatment for advanced or recurrent gastric cancer.

T. Yoshikawa, Ken Kato, Y. Matsumura, 2010 .